Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 106595-91-9 | MDL No. : | MFCD02641650 |
Formula : | C15H14N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BSCQZYGHGGBKLI-UHFFFAOYSA-N |
M.W : | 238.28 | Pubchem ID : | 759495 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.13 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 78.4 |
TPSA : | 32.34 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.96 cm/s |
Log Po/w (iLOGP) : | 2.25 |
Log Po/w (XLOGP3) : | 2.52 |
Log Po/w (WLOGP) : | 1.54 |
Log Po/w (MLOGP) : | 2.26 |
Log Po/w (SILICOS-IT) : | 2.49 |
Consensus Log Po/w : | 2.21 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.27 |
Solubility : | 0.129 mg/ml ; 0.000542 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.85 |
Solubility : | 0.34 mg/ml ; 0.00143 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -5.15 |
Solubility : | 0.00167 mg/ml ; 0.00000701 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.97 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
29% | With tris(2,2′-bipyridine)ruthenium(II) dichloride hexahydrate In acetonitrile at 20℃; Schlenk technique; Inert atmosphere; Irradiation; |
[ 1027-14-1 ]
2-(Diethylamino)-N-mesitylacetamide hydrochloride
Similarity: 0.84
[ 25027-73-0 ]
N-(4-(Aminomethyl)phenyl)acetamide hydrochloride
Similarity: 0.78
[ 1027-14-1 ]
2-(Diethylamino)-N-mesitylacetamide hydrochloride
Similarity: 0.84
[ 25027-73-0 ]
N-(4-(Aminomethyl)phenyl)acetamide hydrochloride
Similarity: 0.78
[ 80636-30-2 ]
3,3-Dimethyl-3,4-dihydroquinoxalin-2(1H)-one
Similarity: 0.71
[ 80484-00-0 ]
6-Chloro-1-methyl-3,4-dihydroquinoxalin-2(1H)-one
Similarity: 0.68
[ 1416352-00-5 ]
1-(3-Chlorobenzyl)-1,2,3,4-tetrahydroquinoxaline dihydrochloride
Similarity: 0.67
[ 354793-04-7 ]
Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate
Similarity: 0.64